Rising tide: Responding to the mental health impact of the COVID‐19 pandemic

Dr. Rauch receives support from Tonix Pharmaceuticals, Wounded Warrior Project (WWP), Department of Veterans Affairs (VA), National Institute of Health (NIH), Woodruff Foundation, and Department of Defense (DOD). Dr. Rauch receives royalties from Oxford University Press. Dr. Simon in the past 3 years has had research funding from the American Foundation for Suicide Prevention, PCORI, Department of Defense, Highland Street Foundation, National Institute of Health, Janssen. She has been a speaker for MGH Psychiatry Academy and consulted for Axovant Sciences, Springworks, Vanda Pharmaceuticals, Praxis Therapeutics, Aptinyx, and Genomind, and Royalty from Wolters Kluwer. Her spouse has equity in G1 Therapeutics. Dr. Rothbaum receives funding from WWP, DOD, NIH, Brain and Behavior Research Foundation (NARSAD), and McCormick Foundation. Dr. Rothbaum receives royalties from Oxford University Press, Guilford, APPI, and Emory University and serves as a consultant to Aptinyx, Nobilis, and Sandoz.